Efficacy and safety of Lu-177-DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study-论文-万方医学网

首页> > Efficacy and safety of Lu-177-DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

Efficacy and safety of Lu-177-DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

导出原文传递

翻译打印收藏纠错

第一作者： Clement, Dominique

作者： Clement, Dominique ^[1] ; Navalkissoor, Shaunak ^[2] ; Srirajaskanthan, Rajaventhan ^[3] ; Courbon, Frederic ^[4] ; Dierickx, Lawrence ^[5] ; Eccles, Amy ^[6] ; Lewington, Valerie ^[7] ; Mitjavila, Mercedes ; Carlos Percovich, Juan ; Lequoy, Benoit ; He, Beilei ; Folitar, Ilya ; Ramage, John

作者单位： Inst Univ Canc Toulouse Oncopole ^[1] Guys & St Thomas Hosp ^[2] Kings Coll Hosp London ^[3] Royal Free Hosp ^[4] Hosp Univ Puerta Hierro Majadahonda ^[5] Hosp Gen Univ Gregorio Maranon ^[6] Novartis Pharma AG ^[7]

关键词 NET GEP-NET panNET Lu-177-DOTATATE NETTER-R CONSENSUS GUIDELINES MANAGEMENT

发布时间 2022-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Efficacy and safety of Lu-177-DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

相似文献

同项目论文

相关期刊

检索历史 清除

Efficacy and safety of Lu-177-DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

相似文献

同项目论文

相关期刊

检索历史清除